PacRay International Holdings Limited provided unaudited consolidated earnings guidance for the year ended 31 December 2021. For the period, it is expected that the Group will record: an increase in revenue by approximately 14% to approximately HKD 106 million for the year ended 31 December 2021, as compared with approximately HKD 93 million for the year ended 31 December 2020; and an increase in loss attributable to owners of the Company to approximately HKD 50 million for the year ended 31 December 2021, as compared with approximately HKD 5 million for the year ended 31 December 2020.